Why the study?
Standard assessments may not fully capture the complexity of older ATTR-CA patients, particularly regarding frailty and mood disorders that influence symptom reporting and clinical decision-making.
Does comprehensive geriatric assessment optimize the management of older patients with transthyretin cardiac amyloidosis?
Does comprehensive geriatric assessment optimize the management of older patients with transthyretin cardiac amyloidosis?
Comprehensive geriatric assessment is essential for older patients with ATTR-CA to accurately evaluate frailty, multimorbidity, and disability, thereby optimizing management and mitigating ageism.
Answers are grounded in this paper and cite their sources.
May support geriatric assessment integration in older ATTR-CA; leaves open prospective outcome validation.
Transthyretin cardiac amyloidosis (ATTR-CA) predominantly affects older adults with multiple chronic conditions, leading to significant physical, cognitive, and emotional challenges. New disease-modifying drugs are effective in early stages, prompting a shift toward comprehensive assessments, including functional capacity and quality of life. However, these assessments may not fully capture the complexity of older ATTR-CA patients, especially regarding frailty and mood disorders, which can influence symptom reporting. Thus, integrating comprehensive geriatric assessment tools into routine clinical practice may be crucial to detect early signs of frailty or functional impairment that could impact outcomes and mitigate futility and ageism in the decision-making process. This review highlights the importance of evaluating multimorbidity, disability, and frailty in older patients with ATTR-CA to optimize management strategies.
No takes yet. Share an insight, caveat, or question.
Fumagalli et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: